Antibody

Category

NYU Langone Among First to Treat COVID-19 Patients with Novel Antibody Arising out of UBC Spinoff Platform & Rapid Lilly Drug Development

NYU Grossman School of Medicine recently began treating patients in a clinical trial to determine whether an antibody therapy known as LY-CoV555 can safely reduce COVID-19 severity. Sponsored by Eli Lilly and Company, this experimental treatment consists of...

University of Toronto Donnelly Centre for Cellular & Biomedical Research in Hot Pursuit of COVID-19 Antibody to Bring to Clinical Trials

A University of Toronto biomedical engineer and team are upbeat about a synthetic antibody developed to help treat those that are ill with COVID-19. By helping those infected with the pathogen and struggle to produce sufficient and timely antibodies to thwart the...

Mount Sinai Licenses SARS-COV-2 Antibody to Sorrento Therapeutics Which Prepares for IND in Anticipation of Phase I Clinical Trial by Q3

Mount Sinai Health System (“Mount Sinai”) and Sorrento Therapeutics (Nasdaq: “SRNE,” “Sorrento”) have inked a deal to investigate an antibody cocktail called COVI-SHIELD™ that potentially can treat COVID-19 patients. This investigational product leverages the work...

UT Austin & VIB-led Team Identify that Special Antibody from Llama can Neutralize SARS-CoV-2 in a Cell Culture

A team of researchers out of University of Texas VIB-UGent Center for Medical Biotechnology and the National Institutes of Health (NIH) recently published a peer-reviewed study revealing that the blood from a South American camelid, the llama, could represent the path...

Pin It on Pinterest